V. Atanasova

Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts.

J. McGrath, A. Fertala, A. South, 2019, The Journal of investigative dermatology.

Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model

G. Schweikert, M. Mitterhauser, M. Bergmann, 2022, bioRxiv.

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.

J. Uitto, J. McGrath, M. Prisco, 2017, The Journal of investigative dermatology.

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa

E. Purdom, K. Tsai, E. Collisson, 2018, Science Translational Medicine.

Precision Medicine for Heritable Skin Diseases-The Paradigm of Epidermolysis Bullosa.

J. Uitto, A. South, Qiujie Jiang, 2018, The journal of investigative dermatology. Symposium proceedings.

enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: potential therapy for recessive dystrophic epidermolysis bullosa

J. Uitto, J. McGrath, M. Prisco, 2017 .

Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma

J. McGrath, A. Hovnanian, M. Prisco, 2019, Clinical Cancer Research.

Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition

M. Bergmann, M. Hengstschläger, H. Dolznig, 2023, International journal of molecular sciences.

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.

J. Uitto, J. McGrath, M. Prisco, 2017, The Journal of investigative dermatology.